Gene Therapy, ‎0969-7128

Journal

1 - 10 out of 16Page size: 10

Publications

  1. 2021
  2. E-pub ahead of print

    Insights and future directions of potential genetic therapy for Apert syndrome: a systematic review

    Soher Jayash, , & , 22 Feb 2021, (E-pub ahead of print) In: Gene Therapy.

    Research output: Contribution to journal › Review article › peer-review

  3. 2011
  4. Published

    Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.

    Jane Steele, Ankit Rao, , , Sarah Berhane, Lucinda Billingham, , , Gordon Ryan, , , Lawrence Young & Neil Steven, 10 Feb 2011, In: Gene Therapy. 18, p. 584-593

    Research output: Contribution to journal › Article

  5. 2008
  6. Published

    Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells

    Benjamin Willcox, Steve Lee, Neil Steven, & , 1 Apr 2008, In: Gene Therapy. 15, 8, p. 625-631 7 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo

    Peter Searle, , , , & , 1 Mar 2008, In: Gene Therapy. 15, 6, p. 424-433 10 p.

    Research output: Contribution to journal › Article

  8. 2007
  9. Published

    Direct positive selection for improved nitroreductase variants using SOS triggering of bacteriophage lambda lytic cycle

    Jane Grove, Eva Hyde & Peter Searle, 1 Apr 2007, In: Gene Therapy. 14, 8, p. 690-698 9 p.

    Research output: Contribution to journal › Article › peer-review

  10. 2006
  11. Published

    Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA

    Vivien Mautner & , 29 Jun 2006, In: Gene Therapy. 13, p. 1579-1587 9 p.

    Research output: Contribution to journal › Article

  12. 2005
  13. Published

    Chick Embryo Lethal Orphan (CELO) virus can be polymer-coated and retargeted to infect mammalian cells

    Vivien Mautner, Kerry Fisher & , 15 Dec 2005, In: Gene Therapy. 13, p. 356-368 13 p.

    Research output: Contribution to journal › Article

  14. Published

    Inhibition of NF-κB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy

    Daniel Palmer, , Peter Searle, & Lawrence Young, 31 Mar 2005, In: Gene Therapy. 12, p. 1187-1197 11 p.

    Research output: Contribution to journal › Article

  15. 2004
  16. Published

    Extended plasma circulation and decreased toxicity of polymer-coated adenovirus

    Vivien Mautner, , , Kerry Fisher & , 24 Jun 2004, In: Gene Therapy. 11, p. 1256-1263 8 p.

    Research output: Contribution to journal › Article

  17. Published

    Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector

    Joanne Gough, Vivien Mautner, , Lawrence Young & Peter Searle, 1 Jan 2004, In: Gene Therapy. 11, p. 1126-1236 111 p.

    Research output: Contribution to journal › Article

Previous 1 2 Next